Researchers find that blocking specific proteins in immune cells can reduce or reverse lung scarring
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...
Research finds a common ingredient found in cough syrups can treat Pulmonary Fibrosis
Researchers from the European Molecular Biology Laboratory have found that dextromethorphan, a common cough syrup ingredient, ...
pulmonaryfibrosisnews2d
Recent snowfall reminds me of how I’ve had to accept limitations
As snow falls at his home, columnist Sam Kirton remembers how he's had to accept limitations, especially since his bilateral ...
Sign of fatal disease that shows on fingers as NHS warns 'see GP'
The disease can cause it to become harder and harder to breathe - and it's key you keep an eye out for symptoms ...
The American Journal of Managed Care6d
Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...
AI-designed spatial gene map identifies early markers of idiopathic pulmonary fibrosis
An international team of researchers has, for the first time, created a detailed map of the location and identity of individual cells in the adult lung, both from healthy lungs and in lungs from ...
EurekAlert!2d
Duke-NUS study targets proteins to reverse lung scarring
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists ...
Everything to know about cystic fibrosis and what causes it
Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.
pharmaphorum9d
Boehringer drug scores in another pulmonary fibrosis trial
The two positive studies mean that Boehringer can now seek approval for nerandomilast with a broad label claim in pulmonary ...
Cough in Idiopathic Pulmonary Fibrosis (IPF) Epidemiology Market Forecast Research 2020-2034
The "Cough in Idiopathic Pulmonary Fibrosis (IPF) - Epidemiology Forecast - 2034" report has been added tAndMarkets.com's offering.The report delivers an in-depth understanding of the Cough in ...
Medscape2d
Novel Triple Combination Therapy May Transform Cystic Fibrosis Care in Children
Once-daily vanzacaftor-tezacaftor-deutivacaftor was safe and well-tolerated in children with cystic fibrosis, while ...